Charles Homcy

Investor type:

Social media:

Available after registration.

Past investments

  • Goldfinch Biopharma
  • Blueprint Medicines
  • Magenta Therapeutics
  • Larimar Therapeutics
  • Constellation Pharmaceuticals
  • Jounce Therapeutics
  • Motus Therapeutics
  • PanOptica
  • Warp Drive Bio
  • Editas Medicine
  • Ember Therapeutics
  • MOMA Therapeutics
  • Relay Therapeutics
  • Decibel Therapeutics
  • CytomX Therapeutics
  • Topica Pharmaceuticals
  • Cibiem, Inc.
  • Alcresta
  • Rhythm Metabolic
  • Agios Pharmaceuticals
  • Rheos Medicines
  • Lotus Tissue Repair
  • Bluebird Bio
  • Corvia Medical
  • Afferent Pharmaceuticals
  • Foundation Medicine
  • Fulcrum Therapeutics
  • Voyager Therapeutics
  • Seventh Sense Biosystems
  • Maze Therapeutics
  • Neon Therapeutics
  • TARIS Biomedical
  • NinePoint Medical
  • Asher Bio
  • MyoKardia
  • Thrive Earlier Detection
  • Celsius Therapeutics
  • Igenica
  • Cedilla Therapeutics
  • Casma Therapeutics
  • Edimer Pharmaceuticals
  • Pliant Therapeutics
  • Sesen Bio, Inc.
  • Element Science
  • Insitro
  • Soffio Medical
  • Revolution Medicines
  • Faze Medicines
  • Ambys Medicines
  • Global Blood Therapeutics
  • Kala Pharmaceuticals
  • Rhythm Pharmaceuticals
  • Nurix Therapeutics
  • Tango Therapeutics
  • SAGE Therapeutics
  • Allena Pharmaceuticals